The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for ...
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in ...
A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party ...
26 October 2023 Biopharmaceutical patent partner leads team of technical advisors and an associate in California | Partner ...
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in ...
Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks.
Budget constraints and keeping up with advancing technology are the top challenges facing European life sciences patent ...
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug ...
The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and ...
There are varying national eligibility requirements that distinguish between treatments of and diagnostics for animals and ...
A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid ...
The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous version of Keytruda as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results